{"id":250872,"date":"2013-08-10T20:45:33","date_gmt":"2013-08-11T00:45:33","guid":{"rendered":"http:\/\/www.eugenesis.com\/stem-cell-therapy-shows-promise-in-repairing-brain-damage\/"},"modified":"2013-08-10T20:45:33","modified_gmt":"2013-08-11T00:45:33","slug":"stem-cell-therapy-shows-promise-in-repairing-brain-damage","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/stem-cell-therapy-shows-promise-in-repairing-brain-damage.php","title":{"rendered":"Stem cell therapy shows promise in repairing brain damage"},"content":{"rendered":"<p><p>    Stem cell therapy shows promise in repairing brain damage    even hours after stroke occurs  <\/p>\n<p>    Durham, NC  Stroke is a major health concern and is a    leading cause of death in the United States, according to the    Center for Disease Control. Despite significant research    efforts, developing treatments that ensure complete recovery    for stroke patients poses an extreme challenge, especially when    more than a few hours have passed between onset of the stroke    and administration of treatment.  <\/p>\n<p>    However, a new study released today in STEM CELLS Translational    Medicine indicates that endothelial precursor cells, which are    found in the bone marrow, umbilical cord blood, and as very    rare cells in peripheral blood, could make a significant    difference for these patients recovery  even in the later    stages of stroke. In animal studies, the treatment minimized    the initial brain injury and helped repair the stroke damage.  <\/p>\n<p>    Previous studies indicated that stem\/progenitor cells derived    from human umbilical cord blood (hUCB) improved functional    recovery in stroke models, noted Branislava Janic, Ph.D., a    member of Henry Ford Health Systems Cellular and Molecular    Imaging Laboratory in Detroit and lead author of the study. We    wanted to examine the effect of hUCB-derived AC133+ endothelial    progenitor cells (EPCs) on stroke development and resolution in    rats.  <\/p>\n<p>    Dr. Janic and his team injected rats that had suffered strokes    with the stem cells. When they later examined the animals using    MRI, they found that the transplanted cells had selectively    migrated to the injured area and that the stem cells stopped    the tissue damage from spreading, instigated regeneration, and    also affected the time course for stroke resolution. A    significant decrease in lesion size also was observed, at a    dose of 10 million cells, as early as seven days after the    strokes onset.  <\/p>\n<p>    This led us to conclude that cord blood-derived EPCs can    significantly contribute to developing more effective    treatments that allow broader time period for intervention,    minimize the initial brain injury and help repair the damage in    later post-stroke phases, Dr. Janic said.  <\/p>\n<p>    The early signs of stroke are often unrecognized, and many    patients cannot take advantage of clot-busting treatments    within the required few hours after stroke onset, said Anthony    Atala, M.D., editor of STEM CELLS Translational Medicine and    director of the Wake Forest Institute for Regenerative    Medicine. In this animal study, a combination of stem cells    shows promise for healing stroke damage when administered 24    hours after the stroke.  <\/p>\n<p>    ###  <\/p>\n<p>    The full article, Intravenous administration of human    umbilical cord blood derived AC133+ endothelial progenitor    cells in rat stroke model reduces infarct volume  magnetic    resonance imaging (MRI) and histological findings, can be    accessed at <a href=\"http:\/\/www.stemcellstm.com\" rel=\"nofollow\">http:\/\/www.stemcellstm.com<\/a>.  <\/p>\n<p>    About STEM CELLS Translational Medicine: STEM CELLS    TRANSLATIONAL MEDICINE (SCTM), published by AlphaMed Press, is    a monthly peer-reviewed publication dedicated to significantly    advancing the clinical utilization of stem cell molecular and    cellular biology. By bridging stem cell research and clinical    trials, SCTM will help move applications of these critical    investigations closer to accepted best practices.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.scoop.co.nz\/stories\/SC1308\/S00025\/stem-cell-therapy-shows-promise-in-repairing-brain-damage.htm\" title=\"Stem cell therapy shows promise in repairing brain damage\">Stem cell therapy shows promise in repairing brain damage<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Stem cell therapy shows promise in repairing brain damage even hours after stroke occurs Durham, NC Stroke is a major health concern and is a leading cause of death in the United States, according to the Center for Disease Control. Despite significant research efforts, developing treatments that ensure complete recovery for stroke patients poses an extreme challenge, especially when more than a few hours have passed between onset of the stroke and administration of treatment. However, a new study released today in STEM CELLS Translational Medicine indicates that endothelial precursor cells, which are found in the bone marrow, umbilical cord blood, and as very rare cells in peripheral blood, could make a significant difference for these patients recovery even in the later stages of stroke <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/stem-cell-therapy-shows-promise-in-repairing-brain-damage.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-250872","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/250872"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=250872"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/250872\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=250872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=250872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=250872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}